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1. Introduction
Because of  its  impairment of  patients'  personal,  social,  and professional  lives,  degenera‐
tive disk disease has become an important  public  health problem with multiple  dimen‐
sions.  The  current  therapeutic  strategy remains  controversial  and is  also  a  medical  and
surgical  challenge.  Conservative  treatment,  based  mostly  based  on  physical  therapy,
constitutes  the  first-line  approach,  but  persistent  symptomatic  disease  may  be  treated
surgically in selected patients [1-4]. Lack of pain relief, stiffening of the lumbar spine, non-
union,  sagittal  balance misalignment,  bone graft  donor site  morbidity,  and,  last  but  not
least, adjacent segment disease are the pitfalls of intervertebral fusion that led to the idea
of total disk replacement (TDR) [5-12]. Since 1966 and Fernström’s first TDR implantation
[13],  many  designs  and  concepts  have  been  proposed  [14-23].  The  devices  are  usually
articulated implants,  and their  mobility depends on the designs of  the bearing surfaces.
Ball-and-socket two-piece prostheses have 3 degrees of freedom in every rotation around
a single fixed center of rotation. Three-piece devices allow additional translation compo‐
nents, providing 5 degrees of freedom. Articulated TDRs have demonstrated their clinical
utility in several patient series. Specifically, the non-inferiority of TDR versus fusion is now
generally accepted [18-20, 24]. However, in vitro testing of the two types of implants reveals
that both designs have biomechanical advantages and limitations.
Because the healthy human intervertebral disk has a deformable elastic structure with 6 degrees
of freedom, elastomeric one-piece intervertebral prostheses might be the most physiological
implant for mimicking physiologic levels of shock absorption and flexural stiffness. Design‐
ing such a device is challenging, especially when we remember the Acroflex® prostheses: the
elastic rubber failed so rapidly in vivo that only 28 were implanted in all [25-26].
© 2013 Lazennec et al.; licensee InTech. This is an open access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The LP-ESP® (lumbar disk prosthesis-elastic spine pad) was developed over a 20-year period.
Improvements in technology have made it possible to solve the problem of the bond between
the elastic component and the titanium endplates. After successful in vitro and in vivo evalua‐
tion, the LP-ESP has been authorized for clinical use in Europe since 2005. The goal of this paper
is to present its innovative concept and the clinical results and radiological outcomes over its 7
years of use. In addition to measuring range of motion, we were specifically interested in the
quality of the kinematics and thus investigated the mean center of rotation at both the instrument‐
ed and adjacent levels. Changes in spinal posture were also a major point of the study.
2. Implant design
The design of the LP ESP® prosthesis is based on the principle of the silent block bush (Figure
1). The LP-ESP ® is a one-piece deformable implant including a central core made of silicone
gel with microvoids and surrounded by polycarbonate urethane (PCU) securely fixed to
titanium endplates. The endplates have five anchoring pegs to provide primary fixation and
are covered by a textured T 40 titanium layer (60 µm thick) and hydroxyapatite to improve
bone ingrowth (Figure 2).
Figure 1. The design of the LP ESP® prosthesis is based on the principle of the silent block bush
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Figure 2. The LP-ESP ® is a one-piece deformable implant including a central core made of silicone gel with microvoids
and surrounded by polycarbonate urethane (PCU) securely fixed to titanium endplates.
Depending on the size, the titanium endplates differ in thickness and angulation. The pros‐
theses are available in two thicknesses (10 and 12 mm), each with 3 angles of lordosis (7°, 9°,
and 11°). Regardless of the model, however, the mechanically active cushion and the mechan‐
ical properties of the prosthesis are the same: The differences in thickness of the lordotic angle
do not affect the prosthesis's mobility or its cushioning, even shock-absorbing, effect.
Accordingly, the peripheral cushion (that is, the annulus) is securely fixed to the titanium alloy
endplates by adhesion-molding technology. This attachment is reinforced by a peripheral
groove without the addition of glue. This process of fixation avoids fluid infiltration and the
risk of fatigue fractures of the interface, despite the very different mechanical properties of the
polymer and the metal endplates. The PCU annulus is stabilized by supplementary pegs
located on the internal surface of both metal endplates. The geometry and position of the pegs,
between the peripheral groove and the central area of the endplates, were planned to control
rotational mobility (Figures 3 and 4 ). The polymer molding was designed to prevent all direct
contact between the upper and lower pegs.
The core or nucleus is composed of a compressible silicone structure containing isobutane
microbubbles. This core is injected after the annulus surrounding it has been molded. Two
titanium caps allow the core to be contained at the moment of the injection. These two pieces
are firmly secured to the titanium plates: they also play a mechanical role by their contactless
fit, because they contribute to limiting shearing during antero-posterior and medio-lateral
translation. The cushioning and compressing effects are obtained on the one hand by the
contactless interlocking of the male and female caps and, on the other hand, by crushing the
annulus between the two metal plates. The same components limit the shearing effect when
the endplates are inclined to the horizontal (Figure 5).
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This design and the adhesion-molding technology differentiate the LP ESP prosthesis from
other monoelastomeric prostheses, for which the constraints of shearing during rotations or
movement are absorbed at the plastic/titanium interface because of the molding technology
Figure 3. The LP-ESP ® is a one-piece deformable implant including a central core made of silicone gel with microvoids
and surrounded by polycarbonate urethane (PCU) securely fixed to titanium endplates.
Figure 4. The geometry and position of the pegs, between the peripheral groove and the central area of the end‐
plates, are planned to control rotational mobility
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used in their design. The attachment is obtained by the penetration of the polymer through
small holes in the endplates. This process creates multiple interfaces and potential fatigue
lesions of the anchoring mechanism due to inhomogeneous loading during flexion-extension,
lateral inclination, and rotation. Thus, in these designs, the plastic monobloc cushion secured
to the titanium plates flows into the space between them during compression, creating an area
of friction and wear.
On the whole, in the LP ESP, the constraints of the interface between the PCU cushion and
its titanium seating are reduced. These are principally constraints of compression:
• between the exterior of the male cap and the interior of the female cap for translations;
• between the pegs for the rotation ;
• between the titanium endplates for flexion.
The principle of the LP ESP® makes it possible to reproduce the anisotropy of the healthy disk,
and the design allows modification of the return torque (without modifying the other param‐
eters of the prosthesis. For example:
• bringing the pegs closer together increases stiffness in rotation without modifying either
translation or compression;
Figure 5. The cushioning and compressing effects are obtained on the one hand by the contactless interlocking of the
male and female caps and, on the other hand, by crushing the annulus between the two metal plates.
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• diminishing the clearance between the male and female caps increases the stiffness of
translation without modifying either rotation or compression;
• modifying the ratio between the small and large diameters of the elliptic form of the cushion
changes the ratios of the return torques between flexion/extension and lateral flexion
without modifying stiffness in compression or rotation.
3. Manufacturing process
The manufacture of this complex implant includes 6 stages, each with its own quality control
for each piece:
• Stage 1: Machining titanium (TA6V) plates and male and female caps and 3-dimensional
check of each unit.
• Stage 2: Preparation of the annulus made of PCU.
◦ Electrochemical treatment of the interior surfaces of the TA6V plates
◦ Preparation and quality control of materials including drying PCU granules at 85°C for
4 h to reduce their humidity to less than 0.1%
◦ Molding the PCU annulus between the two titanium endplates with a 22-ton vertical
injection press (the endplates are pre-positioned in a mold that makes it possible to define
the external geometry and to preserve the ovoid-shaped housing of the core).
◦ Visual check of each unit, followed by testing compression of the implant without its core.
• Stage 3: Preparation of the core.
◦ Placement of the female cap by screwing it in
◦ Injection of a silicone-based component through the opening of the male cap
◦ Screwing in the male cap as the injection starts
◦ Cold polymerization
• Stage 4: Implant checks.
◦ dimensional check of each unit,
◦ testing rigidity while compressed by an axial load)
◦ destructive testing of the first and last pieces of each lot by axial traction of the 2 metal
endplates and then visual examination of the polymer parts (annulus and core).
• Stage 5:Two-stage spraying for final preparation of the anchoring endplates:
◦ the T40 coating by plasma in a vacuum
◦ and the layer of hydroxyapatite by plasma in a controlled atmosphere (inert gas)
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Testing is performed as required by the standards:
ASTM F 1185-03 (2009) Standard Specification for Hydroxylapatite Composition for Surgical
Implants
ISO 5832-2:1999 Surgical implants-- Metal-based products -- Part 2: Non-alloy titanium
ASTM F 1044: Standard test method for Shear Testing of Calcium Phosphate Coatings and
Metallic Coatings
ASTM F 1147: Standard test method for Tension Testing of Calcium Phosphate and Metallic
Coatings
ASTM F 1609: Standard Specification for Calcium Phosphate Coating for Implantable Mate‐
rials.
ISO 13779-1: Hydroxyapatite - Part 1: Hydroxyapatite-based ceramic.
ISO 13779-2: Hydroxyapatite - Part 2: Hydroxyapatite-based coatings.
ISO/CD 13779: Hydroxyapatite - Chemical analysis and characterization of crystallinity and
phase purity
• Stage 6: processing in a class 100 clean room workstation
• Stage 7: sterilization by gamma radiation (min: 25 kgray; max: 40 kgray) according to a
special validated process
4. Design stages
After an initial patent application in 1994 by R. ROY CAMILLE, different avenues of research
were explored, with the scientific expertise of the CEA (Commissariat à l’Energie Atomique,
Fontenay aux Roses,France) and the industrial expertise of FH Industry for further R & D
( Heimsbrunn, France ).
The preliminary stages involved optimizing the choice of PCU, the development of the
attachment of the annulus to the metal endplates without chemical adhesives, the definition
of the pegs and caps, and the implementation of reliable techniques for polymer molding and
injection.
Biocompatibility tests were performed by BIOMATECH, a subsidiary of NAMSA (North‐
wood, Ohio, USA).
Human implantation began in 2004 with the first generation of LP ESP® implants, which used
endplates without lordosis (40 implantations, all complying with the Huriet Act, which defines
French ethical requirements) (Figure 6).
A second generation of implants with lordotic endplates (7°, 9°, and 11°) was introduced in
2005 — LP ESP 1 (Figure 7).
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Figure 6. First generation of lumbar ESP® ( 2004) : endplates without lordosis
Figure 7. Second generation of lumbar ESP® ( 2005) : the shape of the endplates provides lordosis
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A final change was made to the PCU annulus in 2006: its periphery is no longer rectilinear but
was recessed somewhat during the molding process. This change did not modify the attach‐
ment of the cushion of the LP ESP 2® prosthesis but made it possible to reduce its stiffness
during compression by 30% without changing its characteristics for flexion/extension, lateral
incline, or rotation (Figure 8).
Figure 8. Last generation of lumbar ESP® ( 2006) : anterior recess in the PCU annulus to reduce stiffness during com‐
pression
This ESP prosthesis received CE marking in 2005, making it the first elastomeric lumbar
prosthesis to be validated and authorized for marketing.
5. Mechanical properties
The "silent block bush" design of the LP ESP® prosthesis avoids the disadvantage of centers
of rotation that are fixed or controlled by the implant design, as observed in disk prosthe‐
ses based on an articulated design. In addition, in each direction solicited, the prosthesis
offers resistance that increases with the amplitude of the movement. In this sense, the LP
ESP® cannot be compared to first-generation implants. It meets the mechanical criterion of
6  degrees  of  freedom and provides  a  cushioning  effect  while  restoring  elastic  recovery
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properties.  Its  mechanical  properties  are close to those reported in the literature for  the
normal disk (see Table 1).
Pure moments applied in increments up to a
maximum value of 10 N-m
References Level Natural disk
flexion extension Panjabi [27] L4/L5 6°
L5/S1 4°
Campana L1/L2 4°
L4/L5 7°
Yamamoto [28] L1/L2 5°
L4/L5 7.5°
lateral flexion Panjabi L4/L5 4°
L5/S1 2°
Campana [29] L1/L2 4.1°
L4/L5 6.1°
Yamamoto L1/L2 5°
L4/L5 5.7°
Torsion Panjabi L4/L5 2°
L5/S1 1°
Campana L1/L2 2.4°
L4/L5 3.4°
Yamamoto L1/L2 2.3°
L4/L5 2.2°
axial compression Gardner- Morse [30] 2420 N/mm
Variable according to the loading speed, values
retained for 0.1 m/s
Virgin [31] 3000 N/mm
Kemper [32] 1835 N/mm
Bouzakis [33] 1700 N/mm
Elastic recovery» yes
Table 1. Comparison of the mechanical properties of the LP ESP 2® prosthesis with those of the natural disk
6. Biomechanical assessment
The originality of the concept of the ESP® prosthesis led to innovative and intense testing of
various sorts.
6.1. Structural tests
a. Creep tests
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After continuous compression to 1250 kN for 2928 hours (122 days), the height loss was 0.2
mm. In the 8 hours following load removal, the residual height loss was 0.1 mm.
b. Influence of the pegs included in the PCU annulus to control rotations
Tests were performed for combined compression and rotation: the pegs included in the PCU
annulus absorb approximately 50% of the torque.
c. Assessment of the cohesion of the prosthetic cushion and the metal endplates:
The tests were performed for mediolateral and anteroposterior exertion applied to one of the
metal endplates, with the other plate attached to the test machine (figure 9). For implants 12- and
10-mm thick, respectively, a force of 450 and 800 N was required to obtain a gap of 1 mm between
the 2 endplates in the anteroposterior direction and 550 and 600 N in the mediolateral direction.
Figure 9. Assessment of the cohesion of the prosthetic cushion and the metal endplates: the tests were performed for
mediolateral and anteroposterior exertion applied to one of the metal endplates, with the other plate attached to the
test machine
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d. Maximum compression tests
These tests were inspired by the experimental protocol of Virgin [31], who stated that a natural
healthy disk is irreversibly injured by a load of 3 to 11 kN. After application of a force of 4,800
N (100 h) and then 9,200 N (64 h), we did not observe irreversible destruction of the implants.
Compression tests and then compression-shearing at an angle of 45° were performed on the
same samples to obtain successive compressions of 2 mm, 3 mm, and 6 mm. These tests show
the implant's excellent tolerance of these compression–shearing mechanisms.
e. Tests to validate the final stage of coating on the exterior side of the metal plates
Adding a further final coating of porous titanium and spraying hydroxyapatite on the implant
in its permanent form causes its temperature to rise. During the coating process, the disc is
cooled by compressed air so that the ambient temperature remains stable at 21°C. Tests were
performed to verify the absence of any effect from this rise on the mechanically active cushion
in view of the known risk of PCU deterioration at 120°C. These tests demonstrated that the
temperature did not reach a level of risk to the PCU.
6.2. Fatigue and wear tests
Wear tests were conducted in a 3-axis motion simulator according to the following protocol:
• 10 million cycles of flexion, extension, and lateral tilting
• Frequency = 4 Hz
• Loads of 135 to 1350 N
• Inclination of the prosthesis at 45° to reproduce the sagittal orientation of the disk in
functional situations (Figure 10)
• In a demineralized water bath at 37° C
Figure 10. Wear tests were conducted in a 3-axis motion simulator (frequency = 4 Hz, loads of 135 to 1350 N), The
inclination of the prosthesis was 45° to reproduce the sagittal orientation of the disk in functional situations. The gap
between the metal plates was measured after each series of 10 million cycles.
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Tests have even been extended to 40 million cycles without any observation of signs of
mechanical failure. No loss of cohesion was seen. The residual gap between the metal endplates
was 0.55 mm after 20 million cycles and 0.78 mm after 40 million cycles. Loss of mass after 20
million cycles was less than 0.5 % (very low absorption of saline solution and slight degradation
of the endplates coating).
6.3. Biostability tests
This test was conducted according to the requirements of IS0 standard 10993-13/ biological
evaluation of medical devices, Part 13: Identification and quantification of the decay products
of polymer-based medical devices.
The biostability of the implant was assessed by analysis of the particles collected during the
filtration of the demineralized water bath, after a wear test of 10 million cycles under a load
of 1350 N. This study used a scanning electron microscope (SEM LEO1455VP), equipped with
an energy-selective spectrometer (EDS OXFORD). No particles from the component materials
of the prosthesis were found.
The tests looking for salted out or released matter showed the emission of <1 mg/kg methylene
diphenyl 4-4 diisocyanate and of 64.9 mg/kg of 4-4 methylene diamine. These results are
consistent with the data in the literature [34].
6.4. PCU aging test
The specific PCU used for the LP ESP prosthesis is not oxidized during storage (bionate 80A
(DSNM Biomedical,The Netherlands ) according to master file MAF844). Kurz demonstrated
that five years of shelf aging has little effect on the mechanical properties of the PCU and
concludes that the bionate 80A material has greater oxidative stability than ultra-high molec‐
ular weight polyethylene following gamma irradiation in air and exposure to a severe
oxidative challenge [35]. Tests were performed after artificial aging in water at 80°C followed
by 10 million compression cycles at loads ranging from 150 to 1250 N. In the absence of
published standards in the literature, the temperature was determined in comparison with
that recommended for aging plastics, including UHMWPE (ASTM standard F 2003: Acceler‐
ated aging of ultra-high molecular weight polyethylene after gamma irradiation in air) and
the axial load is that recommended by ISO standard 18192 (Intervertebral spinal disk pros‐
theses — Part 1: Loading and displacement parameters for wear testing and corresponding
environmental conditions for test) for wear tests. It was not observed significant changes in
the stiffness of the implants tested.
No modification of the Fournier transform infrared spectrum or any modification of the mean
molecular weight (ASTM standard D 5296) was observed. The chemical composition and
organization of the atomic bonds therefore remained identical because oxidation or natural
cross-linkage would have modified the atomic organization and thus the spectrum. These
results are consistent with the literature [34].
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7. Biocompatibility tests
They were performed by Biomatech (Chasse-sur-Rhône, France ).
All the materials were studied separately and in their final assembly, meeting the specifications
for biocompatibility tests described in ISO standard 10993 (Biological Evaluation of Medical
Devices).
Cytotoxicity test according to ISO standard 10993-5
Sensitization test according to ISO standard 10993-10
Test of irritation or intradermal reaction according to ISO standard 10993-10; acute systemic
toxicity according to ISO standard 10993-11 Chromosomal genotoxicity (Hearts test, and
chromosomal anomalies according to ISO standard 10993-3)
The implants also meet the criteria of the FDA's subacute sensitization test (following FDA -
Guidelines for Toxicity Tests Chapter IV).
8. Clinical results
8.1. Evaluation process:
As of today, more than 2000 LP ESP II prostheses have been implanted. No complication
related to the materials  has been reported.  Our clinical  experience is  based on prospec‐
tive studies of  clinical  and radiologic assessment.  The time points were 3,  6,  12,  and 36
months.  The  intensity  of  back  pain  was  evaluated  with  a  Visual  Analog  Scale  (VAS).
Disability was assessed with the Oswestry Disability Index (ODI) [36-37, 39]. FDA criteria
consider an improvement in the ODI at 2 years equal to or greater than 15% as success.
The SF 36 was used to assess global health status [40]; the quality of life dimension of this
test (SF-36) is composed of two subscores, the physical component summary (PCS) and the
mental component summary (MCS), expressed as percentages [40-44]. The results of this
score were compared to data known for a normal population [45]. In addition, the GHQ28
was used to investigate psychological distress [46].
Radiographs of  the  lumbar spine were prospectively  collected for  the  studies.  The time
points  for  the  radiological  evaluation  were  3,  6,  and  12  months.  The  X-ray  films  were
digitalized  with  the  VXR12®  scanner  (Vidar  System  Corporation)  and  analyzed  with
Spineview®  software (Surgiview Corporation,  Paris,  France),  the precision and reliability
of  which  has  previously  been  reported  [47].  The  analysis  was  performed  by  a  single
observer  who  was  not  involved  in  patient  selection,  surgical  procedures,  or  follow-up
examinations.  Kinematics  parameters  were  studied at  the  level  of  implantation  and the
adjacent  upper  level  on  the  flexion/extension  X-rays.  Range  of  motion  (ROM)  was
measured  to  describe  angular  mobility  quantitatively.  As  Champain  et  al.  [47]  has
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reported 2° accuracy for the measurement of ROM with Spineview®,  we considered that
the prosthesis had no motion if the measured range of motion was less than 3°. For mobile
levels, the mean center of rotation (MCR) was recorded to assess motion qualitatively, as
previously described.  An orthogonal coordinate system centered at  the posterior superi‐
or corner of the lower vertebra, with the X axis along the posterior wall  and the Y axis
along  the  endplate,  was  used  to  describe  the  location  of  the  MCR.  The  percentage  of
MCRs in a correct or normal location was determined according to the method of Tournier
et al [48].
Lateral views in standing position (lumbar spine including femoral heads) were used to assess
the sagittal balance indicators, as defined by Duval and Beaupere [49].
• Sacral slope (SS): angle between the endplate of S1 and the horizontal line,
• Pelvic tilt (PT): the angle between the vertical line and the line connecting the center of the
S1 endplate to the center of the femoral head. The middle of the line connecting the two
femoral heads was used when those were not exactly superimposed;
• Segmental lordosis (SL): the angle between the upper endplate of the superior vertebra and
the lower endplate of the inferior vertebra (for L5S1, the upper L5 endplate and the upper
S1 endplate).
8.2. Clinical results
Clinical outcomes can be assessed from one of our prospective series of 120 patients. The mean
operative time was 92 min (standard deviation, SD: 49 min). The mean blood loss was 73 cc
(SD: 162 cc).
Analysis of the VAS showed a preoperative baseline of 6.6, a strong decrease to 3.7 points at
3 months, and a stable score of 3.6 through 36 months. The VAS thus decreased by 45%.
The baseline preoperative ODI score was 47.3%; it decreased regularly to 19.5% at 36 months,
that is, a reduction of 40%. Overall, 77% of the patients had an ODI score at 36 months that
improved by more than 15 points compared with the preoperative score. At 36 months after
surgery, 90% of the patients showed an improvement of more than 15% compared with the
preoperative value and 83% more than 25% (Tables 2 and 3).
The baseline preoperative GHQ28 score was 64.2; it began to fall at 3 months and remained at
52.2 at 36 months. This indicates an improvement of this psychological score of 18.7%.
The preoperative baseline SF 36 PCS score was 32.3%; it increased to 48.8% at 3 months and
reached 56.8% at 36 months, for an increase of 24,5%.
The preoperative baseline SF 36 MCS score was 42.9%; it increased regularly and reached 57.9%
at 36 months, for an increase of 15%.
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Mean±SD PRE OP 3 MO 6 M 12 M 24 M
VAS 6.6±1.7 3.7±1.9 3.4±2.1 3.5±2.3 3.4±2.4
ODI (%) 47.6±14.6 30.3±17.6 24.5±17.6 21.8±16.3 20.6±17.3
GHQ 28 64.2±15.6 52.5±14.7 52.7±15.8 52.2±15.4 50.6±15.4
SF 36 PCS (%) 32.4±34.8 48.4±39 51.9±39.3 55.6±39.8 59±39.2
SF 36 MCS (%) 42.3±34.0 50.8±34.6 52.8±35.6 53±36.3 58.7±34.6
Table 2. Description of the different evaluations performed
improvement/preoperative status 3 M 6 M 12 M 24 M
ODI improvement of 15 points 53 69 72 76
ODI improvement of 15% 72 82 85 85
ODI improvement of 25% 59 75 82 83
Table 3. Improvement in ODI score compared with preoperative score (in % of the population)
8.3. Radiological outcome
The radiological results can be analyzed from another prospective series of 41 patients (20 L5S1
and 21 L4L5 implantations) for whom postural and kinematic indicators can be evaluated.
Table 4 summarizes the changes in the radiological indicators of sagittal balance over time.
Patients did not have major balance disorders before or after implantation. SS, PT, SL, and DH
all changed significantly between the preoperative period and all other time points.
Pre-op 3 months 6 months
Pelvic incidence (PI) 54.1° ± 14.6
Sacral slope (SS) 36.5° ± 10.6 39.2° ± 5.7 40.8° ± 8.5
Pelvic tilt (PT) 16.7° ± 7.8 15.1° ± 6.7 13.2° ± 8.2
Segmental lordosis (SL) 19.4° ± 6.7 26.6° ± 5.3 27.9° ± 6.9
Discal height (DH) 28.5% ±10.3 50.7% ± 7.4 50.3% ± 5.0
Table 4. Radiological parameters in standing position over time (mean + SD). Changes in SS, PT, SL, and DH were
significant between the preoperative measurements and all other time points.
The average range of motion in flexion-extension at the one-year follow-up was 5.0° (SD: 4.8°)
(Table 5). The ROM increased significantly from 3 to 12 months, from 3.4 ° to 5.0°. With the 3°
cut-off point, 66% of patients demonstrated mobility at one-year. The average ROM for the
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mobile prostheses was 6.9° (SD: 4.5). The average ROM of the prosthesis was 6.4° (SD: 4.9) at
L5S1 and 7.9° (SD: 3.3) at L4L5.
3 months 6 months
ROM at the prosthetic level 3.4° (2.5) 3.1° (2.8)
% of mobile prostheses 66% 60%
ROM of the mobile prostheses 4.4° (2.1) 4.6° (2.8)
ROM at the adjacent upper level 7.5° (5.1) 7.5° (4.2)
Table 5. Range of motion of the prosthesis and the upper adjacent disk over time. Mean (SD). The instrumented level
reached a physiological range of motion similar to the adjacent level above it at between 6 and 12 months.
The MCR was in a normal location for 43% at 3 months, 42% at 6 months, and 87.5% at 12
months. Another prospective series of 74 implants seen at least 2 years after surgery allows
analysis of the prostheses with more than 5° of mobility in flexion-extension: the mean mobility
at L4L5 was 8.2° and at L5S1, 7.6°, for a global mean mobility of 7.9°. Table 6 compares these
values with data from the literature for the same criterion of minimum mobility at 5°.
Author Year Follow-up
Type of
Prothesis
L3-L4
ROM
L4-L5
ROM
L5-S1
ROM
Global
ROM
Gioia [50] 2007 2 Charité III 8 10.3 8 8.7
Bertagonil [51] 2005 2 Prodisc - - - 6.5
Guyer [52] 2009
2
Charité
- 6.5 6 6.3
5 - 6 6.3 6.2
David [53] 1993 1 Charité 2 9.4 6.4 5.9
Siepe [54] 2007 1 Charité III - 7.2 5.9 6.5
Zigler [55] 2012 5 Prodisc - - - 7.7
Delamarter [56] 2011 2 Prodisc L 7.8 6.2 7.0
the series 2012 2 LP ESP - 8.2* 7.6* 7.9*
Table 6. Mobility described in the literature of implants restoring more than 5° of segmental mobility
9. Discussion
The geometry of the LP ESP ® prosthesis allows limited rotation and translation with resistance
to motion aimed at avoiding overload of the posterior facet joints. The center of rotation can
vary freely during motion. This viscoelastic prosthesis achieves 6 degrees of freedom including
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vertical translation; it provides a cushion and may allow shock absorption. It thus differs
substantially from other current prostheses, which are 2- or 3-piece devices involving 1 or 2
bearing surfaces and providing 3 or 5 degrees of freedom, with no or very little resistance, and
no elastic return. A 20-year research program has demonstrated that this concept provides
mechanical properties very close to those of a natural disk.
In addition, the biostability of the implant was demonstrated: no particles from the component
materials of the prosthesis were found after a wear test of 10 million cycles under a load of
1350 N.
These experimental data should be considered in relation to previously reported results from
Nechtow et al. [57] of wear rates of 16.59 ± 0.96 mg/million cycles for ProDisc_ L and 19.35 ±
1.16 mg/million cycles for Charite, and from Grupp et al. [58] of wear rates ranging from 0.14
± 0.06 mg/million cycles to 2.7 ± 0.3 mg/million cycles for Active L.
Moreover, the size and morphology of the UHMWPE particulates observed in these studies
are similar to those described in total hip and knee replacements [59], the osteolytic potential
of which is well known.
Seven years after the first implantation, we can document in a solid and detailed fashion the
course of clinical outcomes and the radiological postural and kinematical behavior of this
prosthesis. The clinical data show early and stable improvement of clinical status, while the
radiological data show immediate improvement of local lordosis and discal height at the
instrumented level and associated adaptation of the sacral slope. At 3 and 12 months, 66% of
cases had physiological mobility at the instrumented level, with secondary self-adjustment of
the center of rotation in flexion/extension.
We acknowledge that more studies with more patients and more follow-up would be useful
in the future to assess long term reliability. Nonetheless, the series reported here describe the
outcomes that might be expected by surgeons and patients over the first 7 years. These
encouraging results are basically similar to the clinical results reported by Tropiano [60] et al.
with the Prodisc II® and the clinical data of the SB Charite®, as reported by McAffee et al [61].
Although the preoperative radiological parameters showed no major imbalance in spinal
posture compared to the global population, SS, PT, and SL improved significantly immediately
after implantation. These results are consistent with those reported in literature with articu‐
lated prostheses [48, 62, 63].
We note that publications do not appear to report significant sagittal misalignments after
prosthetic implantation, whereas lumbar fusion may deleteriously alter the sagittal balance of
the spine, including a decrease in the SS and lumbar lordosis [6,7]. The increased segmental
lordosis might be related to the lordotic shape of the prosthesis but also probably to the fact
that arthroplasty, in contrast to fusion, allows the lumbar spine to find a new balance sponta‐
neously. It has not yet been demonstrated, however, that this self-adaptation of the sagittal
balance protects against adjacent level degeneration. Unlike arthrodesis, the preservation or
restoration of some mobility with a total disk replacement aims at limiting overload of the
adjacent levels.
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The optimal ROM after TDR for limiting adjacent segmental disease has not yet been estab‐
lished. Huang et al [64] reported a series of 42 Prodisc I® implantations with 8.7 years of follow-
up, and 24% of the junctional levels showed radiological signs of degeneration. In their study,
the mean ROM of the disk prostheses adjacent to junctional disease was significantly lower
than the mean ROM of the prostheses adjacent to a radiologically normal disk, i.e., 1.6° versus
4.7°. Prevalence of junctional degeneration was 0% among patients with ROM of 5° or more
and 35% among those with less than 5°. The authors did not conclude that 5° was the trigger
value for avoiding adjacent degeneration, as 65% of patients with less than 5° did not develop
adjacent segmental degeneration. In our series, the LP-ESP® device provides mobility levels
similar to those with articulated prostheses such as Prodisc, which vary according to the series
from 3.8° to 13.2° [62, 64].
We recognize that assessing spinal kinematics with static X-rays in flexion and extension is
subject to bias, given the same-day variations due to inconsistent effort during flexion/
extension [65]. Nonetheless, flexion/extension X-rays are easily available and cause less
irradiation than continuous motion analysis with in vivo fluoroscopy. Quality of movement
is also an issue. The LP-ESP is a novel one-piece deformable but cohesive interbody spacer that
provides 6 full degrees of freedom about the 3 axes. This allows instantaneous axis rotation
change freely, as in the normal disk, while preventing facet overloading.
MCR, initially defined by Pearcy [66], is a pivot point about which a vertebra appears to move
and is thought to reflect the quality of movement of a segment. As disk arthroplasty develops,
this indicator appears to be an informative parameter for studying the quality of spinal
movement imposed by the prosthesis. The coordinates of the MCR for LP-ESP® prosthesis
appears similar to those of the natural disk described in literature. After one year of follow-
up, we found the MCR in a physiological area in 87.5% of the patients. With the same methods,
Tournier et al. [48] reported a normal MCR for 51% of patients receiving the Maverick®, 66%
of those with the Prodisc® (both of which have 3 degrees of freedom), and 80% with the SB
Charite® (5 degrees of freedom). These results suggest that less constrained prostheses, i.e.,
those with more than 3 degrees of freedom, are associated with more normal MCR locations.
In addition, we observed that the MCR location tends to improve during the first year.
However, this must be interpreted while bearing in mind the uncertainty of the MCR meas‐
urement reported by Tournier et al., specifically at the L5-S1 level.
10. Conclusion
The concept of the LP-ESP® prosthesis is different from that of the articulated devices currently
used in the lumbar spine; it allows 6 degree of freedom with elastic return and is intended to
respect the spontaneous instantaneous axis of rotation and to reduce facet forces. Our series
provide encouraging clinical results about pain, function, kinematic behavior and radiological
sagittal balance after implantation of the LP-ESP ®.
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